Risk of developing diabetes in patients with atrial fibrillation taking non vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study
To compare the risk of diabetes development in patients with atrial fibrillation (AF) treated with non vitamin K antagonist oral anticoagulants (NOACs) and warfarin.
Diabetes, obesity metabolism